- Country: Italy
- Summary: Urgent Direct Assignment of the Supply of the Drug Savene Iv 10Fl 500Mg+3Fl Solv for the Antidotal Treatment of Anthracycline Extravasations, Tender Aulss7_2026_00252.
- ITT Ref No: 134727033
- Deadline: 04 Feb 2026
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 9200.00
- Notice Type: Tender
- Document Ref. No.:Login to see details
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINUrgent Direct Assignment of the Supply of the Drug Savene Iv 10Fl 500Mg+3Fl Solv for the Antidotal Treatment of Anthracycline Extravasations, Tender Aulss7_2026_00252. - Italy Tender
The ULSS COMPANY N. 7 PEDEMONTANA, a Government sector organization in Italy, has announced a new tender for Urgent Direct Assignment of the Supply of the Drug Savene Iv 10Fl 500Mg+3Fl Solv for the Antidotal Treatment of Anthracycline Extravasations, Tender Aulss7_2026_00252.. This tender is published on ItalyTenders under ITT Ref No: 134727033 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2026-02-04.
The estimated tender value is EUR 9200.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
